Asian Pacific Journal of Reproduction

: 2022  |  Volume : 11  |  Issue : 5  |  Page : 236--242

L–carnitine improves developmental competence of buffalo oocytes in vitro

Avijit Kumar Modak, Md Nuronnabi Islam, Asma Khatun, Md Hasanur Alam, Ireen Akter, AKM Ahsan Kabir, Md Abul Hashem, Mohammad Moniruzzaman 
 Department of Animal Science, Bangladesh Agricultural University, Mymensingh–2202, Bangladesh

Correspondence Address:
Mohammad Moniruzzaman
Department of Animal Science, Bangladesh Agricultural University, Mymensingh–2202, Bangladesh


Objective: To investigate the effect of L-carnitine on in vitro maturation and subsequent in vitro embryo production of buffalo oocytes. Methods: Cumulus oocyte complexes (COCs) were aspirated from ovaries of slaughtered buffaloes. COCs were classified into good and fair qualities based on morphological observation of numbers and integrity of cumulus cells surrounding the oocyte. Both categories of COCs were placed in in vitro maturation medium with supplementation of different concentrations (0, 0.250, 0.375 or 0.500 mg/mL) of L-carnitine. Oocytes from both qualities were in vitro fertilized and in vitro cultured for 7 days, to examine the developmental competence. Results: Supplementation of L-carnitine to in vitro maturation medium increased the cumulus cell expansion rate of COCs to grade A, and reduced the cumulus cell expansion of COCs to grade B and grade C in both good and fair quality oocytes. Similarly, L-carnitine induced the in vitro meiotic progression of buffalo oocytes to metaphase Π in both good and fair quality oocytes. Additionally, L-carnitine reduced the rate of oocyte degeneration in both good and fair quality oocytes. L-carnitine increased the rate of cleaved formation at day 2 and blastocyst formation at day 7 during in vitro culture in both qualities of oocytes. Moreover, a higher rate of blastocyst production was observed in L-carnitine-treated fair quality oocytes, which was higher than the results in the untreated good quality oocytes. Conclusions: L-carnitine enhances meiotic maturation and subsequent embryo development from both good and fair quality buffalo oocytes.

How to cite this article:
Modak AK, Islam MN, Khatun A, Alam MH, Akter I, Kabir AA, Hashem MA, Moniruzzaman M. L–carnitine improves developmental competence of buffalo oocytes in vitro.Asian Pac J Reprod 2022;11:236-242

How to cite this URL:
Modak AK, Islam MN, Khatun A, Alam MH, Akter I, Kabir AA, Hashem MA, Moniruzzaman M. L–carnitine improves developmental competence of buffalo oocytes in vitro. Asian Pac J Reprod [serial online] 2022 [cited 2023 Mar 25 ];11:236-242
Available from:

Full Text


 1. Introduction

The scarcity of potential oocytes is one of the major limitations of in vitro embryo production in buffaloes. The recovery rate of oocytes per ovary is low in buffaloes compared to bovine[1]. A number of factors including the age of the donor, the time interval between slaughter and oocyte handling, aspiration procedure may affect oocyte quality that contributes to the development of oocytes. Moreover, slaughter-house derived buffalo oocytes have cellular damage that also results in their poor development[2].

In vitro maturation of oocytes, an important step of in vitro embryo production is influenced by the soundness of oocyte cytoplasm and integrity of cumulus cells, size of the follicles, incubation time and culture medium[3]. The quality of oocytes is a crucial factor that reflects the development of oocytes in vitro. Homogenous distribution of oocyte cytoplasm and intact cumulus cell layers are anticipating morphological criteria for subsequent development[4]. Good quality oocytes are surrounded by several layers of dense cumulus cell layers. Fair quality oocytes have few number of loosely attached cumulus cell layers, where oocytes are often partially naked[5],[6]. However, sometimes fair quality oocytes along with good quality ones are included in the experiment of in vitro embryo production to increase the availability of oocytes indeed[7]. So, it is necessary to increase the competence of those fair quality oocytes to support assisted reproductive technologies in buffaloes.

In buffaloes, low fertility is associated with high intra-cytoplasmic lipid content in their oocytes[8]. High lipid content causes degeneration of buffalo oocytes[1]. On the other hand, lipids have a beneficial role during oocyte development in vitro. Intracellular lipid is a source of energy for the generation of mitochondrial adenosine triphosphate (ATP) through ß -oxidation in oocytes and embryos[9]. It has been reported that ATP enhances the developmental competence of oocytes in vitrol 10]. L-carnitine enhances ATP production in oocytes[11]. It has also been reported that L-carnitine improves the maturation of oocytes through increasing lipid metabolism in vitro[12],[13].

L-carnitine is a water soluble and highly polarized amino acid. It is synthesized in the liver from lysine and methionine[14]. Oocytes produce an excessive amount of reactive oxygen species (ROS) in vitro[l5]. During in vitro fertilization (TVF), ROS caused cell death through lipid peroxidation[16]. During in vitro maturation, L-carnitine suppressed intracellular ROS and enhanced antioxidants in oocytes in mouse[17], bovine[18], porcine[19],[20] and sheep[21]. It contributes in total energy metabolism by enhancing oocyte maturation and subsequent development. Thus, it was thought that L-carnitine might improve the developmental potentials of buffalo oocytes, specially less competent fair quality ones. Therefore, the present study was aimed to examine the influence of L-carnitine in nuclear maturation and subsequent development of buffalo oocytes of both good and fair qualities.

 2. Materials and methods

2.1. Chemicals

Unless otherwise stated, all chemicals were purchased from Sigma- Aldrich (St. Louis, MO, USA).

2.2. Collection of cumulus oocyte complexes (COCs)

Buffalo (Bubalus bubalis) ovaries were collected from a local slaughterhouse and transported to the laboratory in physiological saline [0.9% (w/v) NaCl] in a thermo flask. The ovaries were washed 5 times in physiological saline. The ovaries were transferred to Petri dishes containing the same saline solution and trimmed to remove the surrounding tissues and overlying bursa. Further, the ovaries were washed with physiological saline for five times. The COCs were collected by aspiration of 4-8 mm follicles using a syringe (Henke Sass Wolf, Tuttlingen, Germany) with the 18-G needle containing 1-2 mL of aspiration medium [Medium-199 supplemented with 3.2 mg/mL bovine serum albumin (BSA) and 250 μg/mL of gentamycin sulfate]. Then, the COCs were examined under a zoom stereo microscope (CZM6, Labomed, CA, USA) at 40× magnification, and evaluated according to their integrity of cumulus cell layers. Oocytes with compact and dense cumulus cell layers were categorized as good quality and oocytes with lightly attached and sometimes partially naked cumulus cell layers were categorized as fair quality as described by Suresh et al[5]. Total 730 COCs were collected from ovaries. Among the COCs, 145 (19.86%) and 146 (20.00%) were classified as good quality and fair quality oocytes, respectively and used for the experiment. The rest of the COCs were discarded from the experiment. Both good quality and fair quality oocytes consisting of homogenous and healthy cytoplasm were washed subsequently three times in Medium-199 supplemented with 8% fetal bovine serum (Gibco BRL, Grand Island, NY, USA), 0.8 mg/mL Na-pyruvate (29806-54; Nacalai Tesque, Inc., Kyoto, Japan), 1 mM L-glutamine and 50 μg/mL gentamycin sulfate for in vitro maturation. COCs with cytoplasmic degeneration and complete detachment of cumulus cells from oocytes were classified as degenerated ones and excluded from the experiment as described previously[22].

2.3. In vitro maturation

COCs were cultured in TCM-199 with 10% fetal bovine serum, 50 μΜ cysteamine, 0.1 mg/mL Na-pyruvate, 5 μg/mL 17ß-estradiol, 5 μg/mL follicle stimulating hormone (Porcine FSH; NIDDK, Washington, DC, USA) and 0.08 mg/mL gentamycin sulfate for in vitro maturation of oocytes[22]. To elucidate the effects of L-carnitine, the medium was supplemented with either 0, 0.250, 0.375 or 0.500 mg/mL L-carnitine as described previously[18],[19],[20],[21]. Both good and fair quality oocytes were cultured with each concentration of L-carnitine at 38.5 °C for 24 h under 5% CO2 in humidified air. After in vitro maturation, oocytes were observed under an inverted phase contrast microscope (TCM 400; Labomed, CA, USA), and classified among three grades: A, noticeably expanded cumulus cells; B, moderately expanded cumulus cells; and C, less or zero expanded cumulus cells [Figure 1].{Figure 1}

2.4. Assessment of oocyte nuclear maturation

For assessment of nuclear maturation, oocytes were washed in physiological saline and denudated using Pasteur pipette with the help of 0.1% (w/v) hyaluronidase enzyme. Then, the oocytes were fixed in aceto-ethanol (acetic acid: ethanol = 1:3) for 48 h. The oocytes were stained with 1% (w/v) aceto-orcein for 5 min and washed with aceto-glycerol (glycerol: acetic acid: double distilled water = 1:1:3). Oocytes were then examined to assess the nuclear maturation rate under a differential interference contrast microscopy (Olympus Corporation, USA) at 100× magnification and were classified on the basis of their chromosomal configuration in accordance with previous report of Alam et al[23]. In this experiment, after meiotic resumption chromosomal configurations were classified as early diakinesis, late diakinesis, metaphase I and metaphase Π . Oocytes that showed cytoplasmic or nuclear abnormalities were considered as degenerated oocytes.

2.5. IVF

There was a lack of buffalo bull availability in the experimental site. Therefore, frozen semen of a high performing Murrah buffalo bull (No. 107096) were collected from the Department of Livestock Services, Bangladesh. Before use, semen straws were retrieved from the liquid nitrogen container and thawed in a water bath at 38.5 °C for 30 s. The straw was wiped and cut off to pour semen into a 15 mL centrifuge tube. Then, semen were washed twice with working Brackett and Oliphant’s (BO) fertilization medium followed by the method described by Madan et al with slight modifications[24]. BO medium containing semen was centrifuged two times at 115×g for 5 min. The supernatant was removed gently after the centrifugation. A number of 3-4 sperm droplets (100 μL) were prepared using a micropipette. The prepared sperm droplets were incubated for 5 h for capacitation and the motility was observed under a zoom stereo microscope at 100× magnification. Before insemination, COCs were picked up from in vitro maturation medium and washed twice with the fertilization medium supplemented with 10 mg/mL fatty acid-free BSA. Then, the oocytes were added in sperm droplets and incubated for 18 h at 38.5 °C temperature with 5% CO2 in air for IVF.

2.6. Assessment of embryo development

After 18 h of incubation, oocytes were washed at least 3 times in Research Vitro Cleave Medium (Cook Medical, Australia)[25]. Then, putative zygotes were completely denuded from cumulus cells and spermatozoa by gentle pipetting with a fine glass pipette in preincubated in vitro culture medium. The oocytes were examined with the help of a phase-contrast inverted microscopy at 100× magnification for evidence of cleavage. The embryos were cultured following the methodology described by Madan et al with some modifications[24]. The two-third amount of maturation medium was replaced by Research Vitro Cleave Medium supplemented with 10% fatty acid free BSA from the previously stored in vitro maturation droplets. Then, the zygotes were cultured up to 7 days at 38.5 °C temperature with 5% CO2 in air. The day of IVF was designated day 0. In this experiment, observations were taken at days 2 and 7 of in vitro culture to observe the cleavage (2-16 cells) and subsequent development up to blastocyst stage. The cleaved embryo was assessed on the basis of shape, sphericity, thickness of zona pellucida, size of perivitelline space and blastocoele.

2.7. Statistical analysis

Statistical software IBM SPSS version 22 was used to compute different statistic for comparing the treatment effects. Since the few observations of the data set were robust, median (IQR) were applied to evaluate the performance of the treatment at descriptive level, where IQR indicated the inter-quartile range. For generalizing the results, non-parametric test Kruskal-Wallis test was used to find the overall significance of the ANOVA model. For diagnosis the better treatment, Tukey post–hoc test was applied. Data of normal distribution are expressed as mean±standard deviation (mean±SD) from at least four replicated cultures. A P value less than 0.05 was considered as significantly different.

2.8. Ethics statement

All the experimental procedures of this study were approved and supervised by the committee for ethical standard of research in Bangladesh Agricultural University Research System (BAURES), Bangladesh Agricultural University, Mymensingh, Bangladesh (Reference number: BAURES/ESRC/691/2020).

 3. Results

3.1. L-carnitine enhances in vitro maturation of buffalo oocytes

Representative morphologies of cumulus cell expansions are shown in [Figure 1]. Supplementation of 0.375 mg/mL and 0.500 mg/mL L-carnitine significantly increased cumulus cell expansion of grade-A category in good quality oocytes than other groups (P<0.05) [Figure 2]. Significantly higher rate of grade-A expansion was recorded in 0.500 mg/mL L-carnitine treated fair quality oocytes than that of 0 and 0.250 mg/mL of L-carnitine groups (P<0.05). Percentages of OCCs with grade-B expansion of cumulus cells were significantly higher in 0 and 0.250 mg/mL of L-carnitine treated good quality oocytes than 0.500 mg/mL of L-carnitine (P<0.05), while grade-B cumulus cell expansion did not differ in fair quality oocytes. Overall, good quality oocytes showed lower percentages of grade-C expansions than the fair quality oocytes. However, the proportion of grade-C cumulus cell expansion significantly decreased in 0.500 mg/mL L-carnitine treated good quality oocytes than 0 mg/mL L-carnitine treated group (P<0.05). In fair quality oocytes, the percentages of COCs with grade-C cumulus cell expansion decreased significantly in 0.500 mg/mL L-carnitine treated group than 0 and 0.250 mg/mL L-carnitine groups (P<0.05) [Figure 2].{Figure 2}

The results from in vitro maturation of oocytes with the supplementation of L-carnitine are shown in [Table 1]. It was found that 0.500 mg/mL L-carnitine treated good quality oocytes showed a significantly higher rate of metaphase Π (M Π ) oocytes than that of 0.250 mg/mL L-carnitine and 0 mg/mL of L-carnitine groups (P<0.05). A lower percentage of fair quality oocytes reached to the MII stage without L-carnitine supplementation. This percentage increased when oocytes were treated with 0.500 mg/mL L-carnitine, comparable to the percentage of untreated good quality oocytes. However, we did not find any significant difference in oocytes at the MII stage among the fair quality oocyte groups. Neither oocyte quality nor the concentrations of L-carnitine influenced the percentages of oocytes at early diakinesis and late diakinesis stages. However, 0.500 mg/mL L-carnitine treated good quality oocytes showed a significantly lower proportion of MI oocytes than that of 0 and 0.250 mg/mL L-carnitine supplemented groups (P<0.05). Meanwhile, 0.500 mg/mL L-carnitine treated both good and fair quality oocytes showed a significantly lower degeneration rate than that of the untreated groups. These findings suggested that L-carnitine improved the meiotic competence and reduced the degeneration rate of buffalo oocytes.{Table 1}

3.2. Influence of L–carnitine on embryo development

The effects of L-carnitine on the rate of cleavage and embryo development are shown in [Table 2]. The typical morphology of 2-cell embryo (A) and blastocysts (B) are presented in [Figure 3]. In this experiment, 0.500 mg/mL L-carnitine treated good quality oocytes reached significantly higher percentage at cleavage stage than 0 and 0.250 mg/mL L-carnitine supplemented groups (P<0.05). However, we did not find any significant difference in cleavage rates among the fair quality oocyte groups. Similarly, the blastocyst yield was also significantly higher in 0.500 mg/mL L-carnitine treated good quality oocytes than 0 and 0.250 mg/mL L-carnitine treated groups (P<0.05). Moreover, 0.500 mg/mL L-carnitine treated fair quality oocytes showed a higher blastocyst production than the untreated good quality oocytes group.{Table 2}{Figure 3}

 4. Discussion

In the present study, L-carnitine enhanced in vitro maturation of buffalo oocytes. We found that L-carnitine treatment resulted significantly higher rate of embryo development than untreated groups. L-carnitine dose-dependently increased the development of buffalo oocytes in vitro. In mammalian species, the soundness of cumulus cells is necessary for meiotic progression[26],[27]. Cumulus cells support oocyte development by providing nutrients and eliminating suppressive factors from the culture medium[28]. Cumulus cell morphology and cytoplasmic conditions are two key parameters to assess oocyte quality[29],[30]. The classifications of COCs as good quality, fair quality and degenerated according to their morphologies of cumulus cells are vital factors for oocyte developmental competence. According to these criteria, buffalo oocytes were categorized as good quality and fair quality oocytes as bovine oocytes were reportedly classified as more competent and less competent oocytes[31]. In the present study, 19.86% oocytes belonged to good quality and 20.00% were of fair quality during collection. This proportion is comparable with the report of Suresh et al where 17% of fair quality oocytes were harvested[5].

The present study showed that L-carnitine increased the development competence of both good and fair quality oocytes. The percentage of matured oocytes in high concentration (0.500 mg/ mL) of L-carnitine treated fair group was comparable to untreated good quality oocytes. A similar trend was observed in embryo development from fair quality oocytes. Knitlova et al reported that L-carnitine supplementation enhanced the development of bovine oocytes[31]. They suggested that the proportion of MII oocytes obtained from meiotically less competent oocytes were comparable to the untreated more competent oocytes. Our results suggested that supplementing L-carnitine in culture medium buffalo embryo might be produced from fair quality oocytes rather than discarding those. Thus, an opportunity might be created to increase the availability of potential oocytes for embryo production in vitro.

Our study demonstrated that the number of oocytes showing maximum (grade A) expansion was significantly higher in L-carnitine treated good quality oocytes than untreated ones. Results of the present study also revealed that L-carnitine increased cumulus expansion in both good and fair categories of oocytes. However, treatment displayed no such differences in moderate expansion (grade B). A higher concentration of L-carnitine (0.500 mg/mL), in both good and fair quality oocytes, exhibited a significantly lower rate of grade-C expansion. This might be due to L-carnitine induced increase in ATP production from intracellular lipid stores[32].

L-carnitine supplementation reduces the ROS level in oocytes and embryos[32]. L-carnitine reduces H2O2 level in MII oocytes and prevents cell degeneration[19],[33],[34]. Similarly, L-carnitine also inhibits embryo degeneration through development of the chromosomal structures[35]. L-carnitine supplementation increases antioxidants and reduces free radicals, and thus prevents DNA damages[15],[36], Our results suggest that supplementation of L-carnitine in in vitro maturation medium decreases the degeneration rate and increases the subsequent development of buffalo oocytes, which supports the result of a previous study in mouse[35]. However, further molecular study is needed to reveal the cellular signaling cascade of L-carnitine on buffalo oocytes.

In conclusion, L-carnitine enhances in vitro development, prevents degeneration and improves the developmental competence of buffalo oocytes.

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research submitted.


This work was supported by Bangladesh Academy of Science (BAS-USDA; Project No. LS-16/2017), the International Foundation for Science (IFS; reference No B/5219), and Bangabandhu Science and Technology Fellowship Trust of Ministry of Science and Technology, People’s Republic of Bangladesh.

Authors’ contributions

A.K. Modak and M. Moniruzzaman designed and performed the experiments, analysed and interpreted the data. I. Akter, Md. Nuronnabi Islam and A. Khatun conducted in vitro maturation and IVF experiments. A.K. Modak, A.K.M.A. Kabir, M.A. Hashem and Md Hasanur Alam cultured embryo. All authors contributed to designing the experiment, interpreting data and providing critical suggestions to improve the manuscript.


1Gasparrini B. In vitro embryo production in buffalo species: State of the art. Theriogenology 2002; 57: 237-256.
2Neglia G, Gasparrini B, Caracciolo di Brienza V, Di Palo R, Campanile G, Presicce GA, et al. Bovine and buffalo in vitro embryo production using oocytes derived from abattoir ovaries or collected by transvaginal follicle aspiration. Theriogenology 2003; 59: 1123-1130.
3Mahmoud KGM, Al-Shimaa EN. Factors affecting buffalo oocytes maturation. Global Vet 2013; 11: 497-510.
4Balaban B, Urman B. Effect of oocyte morphology on embryo development and implantation. Reprod Biomed Online 2006; 12: 608-615.
5Suresh KP, Nandi S, Mondal S. Factors affecting laboratory production of buffalo embryos: A meta-analysis. Theriogenology 2009; 72(7): 978-985.
6Khandoker MA, Imai K, Takahashi T, Hashizume K. Role of gelatinase on follicular atresia in the bovine ovary. Biol Reprod 2001; 65: 726-732.
7Ravindranatha BM, Nandi S, Raghu HM, Reddy SM. In vitro maturation and fertilization of buffalo oocytes: Effects of storage of ovaries, IVM temperatures, storage of processed sperm and fertilization media. Reprod Domest Anim 2003; 38(1): 21-26.
8Ledda S, Leoni G, Bogliolo L, Naitana S. Oocyte cryopreservation and ovarian tissue banking. Theriogenology 2001; 55: 1359-1371.
9Sturmey RG, Reis A, Leese HJ, McEvoy TG. Role of fatty acids in energy provision during oocyte maturation and early embryo development. Reprod Domest Anim 2009; 44: 50-58.
10Stojkovic M, Machado SA, Stojkovic P, Zakhartchenko V, Hutzler P, Gonçalves PB, et al. Mitochondrial distribution and adenosine triphosphate content of bovine oocytes before and after in vitro maturation: Correlation with morphological criteria and developmental capacity after in vitro fertilization and culture. Biol Reprod 2001; 64(3): 904-909.
11Hashimoto S. Application of in vitro maturation to assisted reproductive technology. J Reprod Dev 2009; 55: 1-10.
12Ghanem N, Ha AN, Fakruzzaman M, Bang JI, Lee SC, Kong IK. Differential expression of selected candidate genes in bovine embryos produced in vitro and cultured with chemicals modulating lipid metabolism. Theriogenology 2014; 82: 238-250.
13Spricigo JF, Morato R, Arcarons N, Yeste M, Dode MA, Lopez-Bejar M et al. Assessment of the effect of adding L-carnitine and/or resveratrol to maturation medium before vitrification on in vitro matured calf oocytes. Theriogenology 2017; 89: 47-57.
14Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J 2002; 361: 417-429.
15Ali AA, Bilodeau JF, Sirard MA. Antioxidant requirements for bovine oocytes varies during in vitro maturation, fertilization and development. Theriogenology 2003; 59: 939-949.
16Tatemoto H, Sakurai N, Muto N. Protection of porcine oocytes against apoptotic cell death caused by oxidative stress during in vitro maturation: Role of cumulus cells. Biol Reprod 2000; 63(3): 805-810.
17Zare Z, Masteri Farahani R, Salehi M, Piryaei A, GhaffariNovin M, Fadaei Fathabadi F, et al. Effect of L-carnitine supplementation on maturation and early embryo development of immature mouse oocytes selected by brilliant cresyle blue staining. J Assist Reprod Genet 2015; 32(4): 635-643.
18Sovernigo TC, Adona PR, Monzani PS, Guemra S, Barros F, Lopes FG, et al. Effects of supplementation of medium with different antioxidants during in vitro maturation of bovine oocytes on subsequent embryo production. Reprod Domest Anim 2017; 52(4): 561-569.
19Somfai T, Kaneda M, Akagi S, Watanabe S, Haraguchi S, Mizutani E, et al. Enhancement of lipid metabolism with L-carnitine during in vitro maturation improves nuclear maturation and cleavage ability of follicular porcine oocytes. Reprod Fertil Dev 2011; 23: 912-920.
20You J, Lee J, Hyun SH, Lee E. L-carnitine treatment during oocyte maturation improves in vitro development of cloned pig embryos by influencing intracellular glutathione synthesis and embryonic gene expression. Theriogenology 2012; 78: 235-243.
21Mishra A, Reddy IJ, Gupta PS, Mondal S. L-carnitine mediated reduction in oxidative stress and alteration in transcript level of antioxidant enzymes in sheep embryos produced in vitro. Reprod Domest Anim 2016; 51: 311-323.
22Islam MN, Alam MH, Khatun A, Akter I, Modak AK, Hashem MA, et al. Effects of stem cell factor on in vitro growth of buffalo oocytes. Theriogenology 2020; 142: 114-119.
23Alam MH, Lee J, Miyano T. Inhibition of PDE3A sustains meiotic arrest and gap junction of bovine growing oocytes in in vitro growth culture. Theriogenology 2018; 118: 110-118.
24Madan ML, Chauhan MS, Singla SK, Manik RS. Pregnancies established from water buffalo (Bubalus bubalis) blastocysts derived from in vitro matured, in vitro fertilized oocytes and co-cultured with cumulus and oviductal cells. Theriogenology 1994; 42: 591-600.
25Saini M, Selokar NL, Palta P, Chauhan MS, Manik RS, Singla SK. An update: Reproductive hand made cloning of water buffalo (Bubalus bubalis). Animal Reprod Sci 2018; 197: 1-9.
26Warriach HM, Chohan KR. Thickness of cumulus cell layer is a significant factor in meiotic competence of buffalo oocytes. J Vet Sci 2004; 5(3): 247-251.
27Mahmoud KGM, Mohamed YMA, Amer MA, Noshy MM, Nawito MF. Aneuplidy in in vitro matured buffalo oocytes with or without cumulus cells. Nat Sci 2010; 8: 46-51.
28Russell DL, Gilchrist RB, Brown HM, Thompson JG. Bidirectional communication between cumulus cells and the oocyte: Old hands and new players? Theriogenology 2016; 86(1): 62-68.
29Nagano M, Katagiri S, Takahashi Y. Relationship between bovine oocyte morphology and in vitro developmental potential. Zygote 2006; 14(1): 5361.
30Hoshino Y. Updating the markers for oocyte quality evaluation: Intracellular temperature as a new index. Reprod Med Biol 2018; 17(4): 434-441.
31Knitlova D, Hulinska P, Jeseta M, Hanzalova K, Kempisty B, Machatkova M. Supplementation of L-carnitine during in vitro maturation improves embryo development from less competent bovine oocytes. Theriogenology 2017; 102: 16-22.
32Dunning KR, Robker RL. Promoting lipid utilization with L-carnitine to improve oocyte quality. Anim Reprod Sci 2012; 134: 69-75.
33Wu GQ, Jia BY, Li JJ, Fu XW, Zhou GB, Hou YP, et al. L-carnitine enhances oocyte maturation and development of parthenogenetic embryos in pig. Theriogenology 2011; 76: 785-793.
34Ye J, Li J, Yu Y, Wei Q, Deng W, Yu L. L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway. Regul Pept 2010; 161: 58-66.
35Mansour G, Abdelrazik H, Sharma RK, Radwan E, Falcone T, Agarwal A. L-carnitine supplementation reduces oocyte cytoskeleton damage and embryo apoptosis induced by incubation in peritoneal fluid from patients with endometriosis. Fertil Steril 2009; 91: 2079-2086.
36Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci 2006;78:803-811.